Analyst Recommendations

BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -1.99%

Scotiabank analyst issues PERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Sector Outperform.CVX was trading at $147.89 at issue of the...

February 2, 2024   CVX 1.98%

Raymond James analyst issues OUTPERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Outperform.CVX was trading at $147.89 at issue of the...

February 2, 2024   CVX 1.98%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -1.99%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -1.99%

BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -1.99%

BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 1, 2024   MA -1.99%

RBC Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 1, 2024   MA -1.99%

RBC Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 1, 2024   MA -1.99%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 1, 2024   MA -1.99%